Published on 24 Apr 2024 on Zacks via Yahoo Finance
Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2024, Biogen Inc. (BIIB) reported revenue of $2.29 billion, down 7% over the same period last year. EPS came in at $3.67, compared to $3.40 in the year-ago quarter.
The reported revenue represents a surprise of -1.09% over the Zacks Consensus Estimate of $2.32 billion. With the consensus EPS estimate being $3.45, the EPS surprise was +6.38%.